Side-by-side comparison of AI visibility scores, market position, and capabilities
Lyell Immunopharma develops next-generation CAR-T cell therapies designed to overcome T cell exhaustion and treat solid tumors, the frontier of cell therapy.
Lyell Immunopharma is a clinical-stage cell therapy company founded in 2018 by Rick Klausner and publicly traded on Nasdaq. The company focuses on next-generation CAR-T therapies that address the key limitations of first-generation products, particularly the exhaustion and dysfunction of engineered T cells that limits efficacy especially against solid tumors. Lyell has developed proprietary T cell reprogramming technologies including gene overexpression approaches that maintain T cell stemness and fitness during manufacturing and after infusion. The company is applying these technologies to both hematological malignancies and solid tumors in a pipeline of clinical programs. Lyell has established a research collaboration with GlaxoSmithKline to combine cell therapy expertise. While first-generation CAR-T products have demonstrated remarkable responses in blood cancers, Lyell is focused on the much larger unmet need in solid tumors where current CAR-T therapies have shown limited efficacy. The company represents the scientific evolution of the cell therapy field toward more durable and broadly applicable treatments.
OpsLevel is a developer portal and service catalog for tracking service ownership, maturity scorecards, and production readiness across microservices.
OpsLevel is a developer portal platform that gives engineering organizations visibility into the services they operate, who owns them, and how mature they are relative to internal engineering standards. At its core, OpsLevel maintains a service catalog that maps every microservice, repository, and infrastructure component to a team owner, populating metadata automatically from integrations with GitHub, GitLab, PagerDuty, Datadog, and cloud providers. This catalog becomes the authoritative source of truth for answering questions like who to contact about a service, what tier of reliability it requires, and what dependencies it has — questions that are often unanswerable at engineering organizations that have grown past the point where everyone knows everything.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.